Activation of CDK7 significantly enhances the recruitment of MED1 to the super-enhancer of LIMD1-AS1, thereby enhancing the expression of LIMD1-AS1 and promoting glioma cell proliferation. The gene discussed is LIMD1; the disease is central nervous system cancer.